Hello, everyone, and nice to see you again. A spot of rain is falling on the Pharmalot corporate campus, but our spirits remain sunny. Of course, a cup or two of stimulation can help - our flavor this morning is Rain Forest Nut. Meanwhile, there are meetings and deadlines that await. So here are some interesting items to help you along. Have a great day and do stay in touch...
Pfizer To Move Antibacterials Research To Shanghai (The Day)
Abbott CEO Compensation Fell 2.5 Percent Last Year (Dow Jones)
DEA Seizes Execution Drug In Georgia (Associated Press)
Japan Nuclear Catastrophe Spurs Debate Over Radiation Pills (Bloomberg News)
Those $4 Rx Programs Can Save US Billions (Reuters)
Cephalon Sues US Over Fentora Generic Approval (Bloomberg News)
Aegerion Receives Orphan Status For Lipid Drug (Associated Press)
China Approves Novo Nordisk Victoza Med (Reuters)
Roche Acquires PVT Diagnostics (Pharma Times)
Impax Parkinson's Med Does Well In Phase III (South Florida Business Journal)